Multiple studies have demonstrated that mutations of IFN-γ axis and consequent loss of JAK/STAT contribute to immune escape of tumor cells and by that leads to primary or acquired resistance to ICI therapy via incapacity of up-regulating the expression of PD-L1 and MHC-I (73, 78, 84). The gene discussed is CD274; the disease is neoplasm.